Citation
Corrigendum to “ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis” [Atherosclerosis 422, (2026), 121927]. // Atherosclerosis. – URL: https://www.sciencedirect.com/science/article/pii/S0021915026012967?dgcid=rss_sd_all
Corrigendum to “ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis” [Atherosclerosis 422, (2026), 121927]. Atherosclerosis. https://www.sciencedirect.com/science/article/pii/S0021915026012967?dgcid=rss_sd_all
“Corrigendum to “ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis” [Atherosclerosis 422, (2026), 121927].” Atherosclerosis.
@article{article36965,
title = {Corrigendum to “ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis” [Atherosclerosis 422, (2026), 121927]},
journal = {Atherosclerosis},
url = {https://www.sciencedirect.com/science/article/pii/S0021915026012967?dgcid=rss_sd_all}
}